A Randomized, Double-Blind, Placebo-Controlled Study of

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects with Seizure Clusters
StatusActive
Effective start/end date4/5/1112/31/20

Funding

  • PHARMANET, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.